These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22043058)

  • 41. Predictive molecular markers in the adjuvant therapy of breast cancer: state of the art in the year 2002.
    Di Leo A; Cardoso F; Durbecq V; Giuliani R; Mano M; Atalay G; Larsimont D; Sotiriou C; Biganzoli L; Piccart MJ
    Int J Clin Oncol; 2002 Aug; 7(4):245-53. PubMed ID: 12202978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?
    Generali D; Ardine M; Strina C; Milani M; Cappelletti MR; Zanotti L; Forti M; Bedussi F; Martinotti M; Amoroso V; Sigala S; Simoncini E; Berruti A; Bottini A
    J Natl Cancer Inst Monogr; 2015 May; 2015(51):32-5. PubMed ID: 26063883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progress in breast cancer: overview.
    Arteaga CL
    Clin Cancer Res; 2013 Dec; 19(23):6353-9. PubMed ID: 24298065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene-Expression-Based Predictors for Breast Cancer.
    Gupta A; Mutebi M; Bardia A
    Ann Surg Oncol; 2015 Oct; 22(11):3418-32. PubMed ID: 26215189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bridging the gap between translational research and clinical application.
    Miller WR; Larionov AA
    J Natl Cancer Inst Monogr; 2011; 2011(43):134-7. PubMed ID: 22043060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene-expression microarrays provide new prognostic and predictive tests for breast cancer.
    Gong Y; Symmans WF; Pusztai L
    Pharmacogenomics; 2007 Oct; 8(10):1359-68. PubMed ID: 17979510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using molecular profiles to tailor treatment in breast cancer: are they ready for prime time?
    Peintinger F
    Curr Opin Obstet Gynecol; 2014 Feb; 26(1):21-6. PubMed ID: 24346126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of gene-expression profiling to recommend adjuvant chemotherapy for breast cancer.
    Henry NL; Hayes DF
    Oncology (Williston Park); 2007 Oct; 21(11):1301-9; discussion 1311, 1314, 1319. PubMed ID: 18080616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and molecular aspects of breast cancer: Targets and therapies.
    Godone RLN; Leitão GM; Araújo NB; Castelletti CHM; Lima-Filho JL; Martins DBG
    Biomed Pharmacother; 2018 Oct; 106():14-34. PubMed ID: 29945114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A pathway-based approach to identify molecular biomarkers in cancer.
    Stevenson M; Potti A
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S620-4. PubMed ID: 22048630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.
    Lang JE; Wecsler JS; Press MF; Tripathy D
    J Surg Oncol; 2015 Jan; 111(1):81-90. PubMed ID: 25091830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel targeted therapies for the treatment of penile cancer.
    Agarwal G; Gupta S; Spiess PE
    Expert Opin Drug Discov; 2014 Aug; 9(8):959-68. PubMed ID: 24896220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What's new in decoding breast cancer.
    de Snoo F
    Med Princ Pract; 2012; 21(2):99-100. PubMed ID: 22025041
    [No Abstract]   [Full Text] [Related]  

  • 54. Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.
    Yip L
    J Surg Oncol; 2015 Jan; 111(1):43-50. PubMed ID: 25155423
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of anthracyclines in adjuvant chemotherapy of breast cancer: a critical appraisal.
    Mouridsen HT
    Recent Results Cancer Res; 1996; 140():191-9. PubMed ID: 8787062
    [No Abstract]   [Full Text] [Related]  

  • 56. Do online prognostication tools represent a valid alternative to genomic profiling in the context of adjuvant treatment of early breast cancer? A systematic review of the literature.
    El Hage Chehade H; Wazir U; Mokbel K; Kasem A; Mokbel K
    Am J Surg; 2018 Jan; 215(1):171-178. PubMed ID: 28622841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A big trial for a new technology: TransBIG Project takes microarrays into clinical trials.
    Tuma RS
    J Natl Cancer Inst; 2004 May; 96(9):648-9. PubMed ID: 15126595
    [No Abstract]   [Full Text] [Related]  

  • 58. Harmonizing gene signatures to predict benefit from adjuvant chemotherapy in early breast cancer.
    Criscitiello C; Viale G; Curigliano G
    Curr Opin Oncol; 2019 Nov; 31(6):472-479. PubMed ID: 31593974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adjuvant chemotherapy--yes or no? Prognostic markers in early breast cancer.
    Piccart-Gebhart MJ; Sotiriou C
    Ann Oncol; 2007 Dec; 18 Suppl 12():xii2-7. PubMed ID: 18083699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Statistical methods applied to omics data: predicting response to neoadjuvant therapy in breast cancer.
    Ternès N; Arnedos M; Koscielny S; Michiels S; Lanoy E
    Curr Opin Oncol; 2014 Nov; 26(6):576-83. PubMed ID: 25210869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.